This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Stephen M. Ostroff, M.D., Acting Commissioner of Food and Drugs

No Significant Event

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

Event Date : 04/13/2017 - 04/13/2017
Location : Washington, DC
Subject : Drug Pricing
FDA Participant/Group : JOHN KALAVRITINOS;
Non FDA Participant/Group : Alicia Hennie, Jay Taylor, Jim Stanel, Kelly Goldberg, Lisa Joldersma, Lori Reilly, Randy Burkholder, Rodger Currie, Sylvia Yu (Pharmaceutical Research and Manufacturers of America); Kyle McGowan (HHS Intergovermental and External Affairs); John Graham, John O'Brien (HHS Assistant Secretary for Planning and Evaluation); Amanda Street, John Brooks, Paula Stannard (HHS Office of the Secretary);

Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Acting Deputy Commissioner for Operations

No Significant Event

Official Name : Erik Mettler, Acting Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Peter Lurie, M.D., M.P.H., Associate Commissioner for Policy and Planning

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs

No Significant Event

Official Name : Janice Soreth, Associate Commissioner for Special Medical Programs

No Significant Event

Official Name : Luciana Borio, M.D., Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date : 04/11/2017 - 04/11/2017
Location : Arlington, VA
Subject : An Introduction to the Glioblastoma Multiforme (GBM) Adaptive Global Innovative Learning Environment (AGILE) Trial
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 04/13/2017 - 04/13/2017
Location : Minneapolis, MN
Subject : Presented at the Design of Medical Devices Conference
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date : 04/11/2017 - 04/11/2017
Location : Washington DC
Subject : 40th Annual National Food Policy Conference (Keynote Speaker) FDA Policy
FDA Participant/Group : N/A
Non FDA Participant/Group : N/A

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

Event Date : 04/12/2017 - 04/12/2017
Location : Rockville, Maryland
Subject : Center for Veterinary Medicine Overview
FDA Participant/Group : TRACEY FORFA; WILLIAM FLYNN; STEVEN VAUGHN; NADINE STEINBERG; DANIEL MCCHESNEY;
Non FDA Participant/Group : Karin Hoelzer, Kathy Talkington, Kyle Kinner, Nora Wong (Pew Charitable Trusts);

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date : 04/11/2017 - 04/11/2017
Location : Jefferson, Arkansas
Subject : Visit to the National Center for Toxicological Research
FDA Participant/Group : N/A
Non FDA Participant/Group : Representative Bruce Westerman (R-AR);

Official Name : Elizabeth H. Dickinson, Esq., Chief Counsel

No Significant Event